Detalles de la búsqueda
1.
Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects.
Mol Psychiatry
; 24(7): 1040-1052, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29487402
2.
Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression.
Neural Plast
; 2015: 858251, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26137324
3.
Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder.
Int J Neuropsychopharmacol
; 18(1)2014 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-25539512
4.
Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression.
Br J Clin Pharmacol
; 74(2): 304-14, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22295895
5.
Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression.
J Affect Disord
; 232: 310-315, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29501990
6.
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Arch Gen Psychiatry
; 63(8): 856-64, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16894061
7.
Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials.
J Affect Disord
; 218: 195-200, 2017 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28477497
8.
The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder.
J Psychopharmacol
; 31(12): 1570-1577, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29039254
9.
Rating depression over brief time intervals with the Hamilton Depression Rating Scale: standard vs. abbreviated scales.
J Psychiatr Res
; 61: 40-5, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25592045
10.
Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant.
J Psychiatr Res
; 68: 68-73, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26228403
11.
D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression.
Psychopharmacology (Berl)
; 232(2): 399-409, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25056852
12.
Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.
J Clin Psychiatry
; 75(9): e932-8, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25295436
13.
Do the dissociative side effects of ketamine mediate its antidepressant effects?
J Affect Disord
; 159: 56-61, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24679390
14.
Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety.
J Psychiatr Res
; 58: 161-6, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25169854
15.
Clinical predictors of ketamine response in treatment-resistant major depression.
J Clin Psychiatry
; 75(5): e417-23, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24922494
16.
A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression.
Biol Psychiatry
; 74(4): 257-64, 2013 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23206319
17.
Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression.
Biol Psychiatry
; 72(7): 555-61, 2012 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22521148
18.
Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.
Biol Psychiatry
; 71(11): 939-46, 2012 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22297150
19.
Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.
J Clin Psychiatry
; 71(12): 1605-11, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20673547
20.
A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.
Arch Gen Psychiatry
; 67(8): 793-802, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20679587